MAR 30, 2016 8:43 AM PDT

Recruiting Plant Peptides to Treat Multiple Sclerosis

WRITTEN BY: Kara Marker
Multiple Sclerosis (MS) is an autoimmune disease characterized by chronic inflammation, a result from an overexcited, misdirected immune response. A synthesized plant polypeptide called cyclotide is found in a variety of common plants, and it has the capability to reduce MS-related inflammation to the point where the disease can be curbed at a very early stage.

 MS is currently incurable, with available treatments to reduce the rate of progression including harsh side effects. The overactive inflammatory response causing MS stems from the destruction of myelin sheaths, the components of the nervous system that insulate nerve fibers. The current study indicating the future use of cyclotides as a more effective treatment was completed at the Medical University of Vienna and recently published in the journal PNAS.
“This could slow down the course of the disease in general,” said Christian Gruber, PhD, Chief Researcher at the Center for Physiology and Pharmacology at the university, said about the clinical sue of cyclotides.
In an animal model of MS, the research time orally administrated cyclotides and saw reduced symptoms of MS to the point where the most successful case showed no further progression of MS clinical signs. These preliminary studies mean that as soon as people start to show functional neurological problems that are characteristic of MS and receive a confirmative diagnose of MS via magnetic resonance imaging (MRI), the drug could be administered to prevent any further progression of the disease.
Cyclotides can be isolated from common plants like coffee, cucurbits, grass, and nightshade. It is highly advantageous that the drug develop from these macrocyclic peptides can be taken orally; most current treatments have to be administered intravenously.
By suppressing interleukin-2, an inflammatory cytokine that promotes the division of T lymphocytes, cyclotides reduce inflammation in patients with MS. When a reasonable cause instigates interleukin-2 production and activation of T lymphocytes, this is a protective pathway for the body. However, cases of MS are characterized by an inappropriate release of interleukin-2, leading to unnecessary inflammation, so suppressing the cytokine will successful reduce the severity of MS.
Additionally, cyclotide-based drugs have the potential to treat other autoimmune diseases characterized by an “overactive, misdirected immune response.”
Researchers from the Medical University of Vienna have authorized further development to be carried out at a pharmaceutical company called Cyxone.  A clinical trial testing the drug could begin as early as the end of 2018. More than 2.5 million people worldwide are affected by MS, and cyclotide-based drugs could be the first medication to truly make a difference in their lives.
Source:  Medical University of Vienna
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
APR 24, 2020
Health & Medicine
APR 24, 2020
Study Shows Marijuana Withdrawal is Real
Whether or not an addiction to marijuana is a risk of the drug has been widely debated, with the general population typi ...
APR 26, 2020
APR 26, 2020
Can you Get PTSD from the COVID-19 Pandemic?
Following a traumatic experience, some experience intense flashbacks, nightmares, irritability, anger and fear. Key symp ...
MAY 15, 2020
MAY 15, 2020
Cardiovascular Disease Mortality is Greater in Rural Areas
A wide variation in cardiovascular disease mortality rates has been noted among counties in the United States. Residents ...
MAY 24, 2020
Cell & Molecular Biology
MAY 24, 2020
Common Chemicals May Contribute to Obesity
Several explanations have been proposed to answer the question of why obesity has been on the rise for many years in the ...
MAY 24, 2020
MAY 24, 2020
Cavity-Causing Microbes Are Protected by Rings of Sugars and Germs
Bacteria can form tough communities called biofilms, which are difficult to remove and can resist the effects of antimic ...
MAY 28, 2020
MAY 28, 2020
The Oncogenic Hazard of a Potential Alzheimer's Treatment
Breast cancer remains one of the most common cancers around the world. Triple-Negative Breast Cancer (TNBC) is a sub-typ ...
Loading Comments...